Recent research advances in the treatment of myopic foveoschisis
10.13389/j.cnki.rao.2025.0087
- VernacularTitle:近视性黄斑劈裂治疗方法最新研究进展
- Author:
Chengmin XI
1
;
Yang LÜ
Author Information
1. 730050 甘肃省兰州市,中国人民解放军联勤保障部队第九四○医院眼科中心;730000 甘肃省兰州市,甘肃中医药大学第一临床医学院;730050 甘肃省兰州市,中国人民解放军联勤保障部队第九四○医院基础医学实验室,甘肃省干细胞与基因药物重点实验室
- Publication Type:Journal Article
- Keywords:
myopia;
myopic foveoschisis;
anti-vascular endothelial growth factor drugs;
vitreoretinal surgery;
macu-lar buckle
- From:
Recent Advances in Ophthalmology
2025;45(6):495-499
- CountryChina
- Language:Chinese
-
Abstract:
In recent years,myopic foveoschisis(MF)has become a common complication in individuals with high my-opia,mainly due to the combination of the inward traction of vitreoretinal adhesions and the outward traction exerted on the retina by posterior scleral staphyloma.As one of the common complications of pathological myopia,MF seriously af-fects the vision of patients.The main surgical procedures for highly myopic patients with MF include vitrectomy,macular buckle,and posterior scleral reinforcement.However,there are still controversies about the need for internal limiting membrane peeling and gas tamponade.In addition to surgical treatment,drug treatment is also under continuous explora-tion.A variety of drugs have been used to improve visual function through different mechanisms.This paper summarizes the current treatment methods for patients with MF,in an attempt to provide reference for researchers.
